Charles River Laboratories Intl. Inc vs Lockheed Martin Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while Lockheed Martin Corporation trades at $596.5 (market cap $137.96B). The key difference: Lockheed Martin Corporation is far larger — about 10.2× Charles River Laboratories Intl. Inc's market cap, and Lockheed Martin Corporation pays a 2.31% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | LMT | |
|---|---|---|
Market Cap | $13.46B | $137.96B |
Sector | Health | Industrials |
52-Week High | $282.00 | $676.70 |
52-Week Low | $145.57 | $431.56 |
Enterprise Value | $16.30B | $154.71B |
Dividend Yield | — | 2.31% |
Trailing returns across standard periods
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →